Classic and Cutting-Edge Strategies for the Management of Early Pregnancy Loss

Obstetrics and Gynecology Clinics of North America

Volumn 41, Issue 1, 2014, Pages 1-18

  Brezina, Paul R ^a   Kutteh, William H ^a  

^a Fertility Associates of Memphis   (United States)

Author keywords

Aneuploid; Antiphospholipid; Heparin; Lupus anticoagulant; Miscarriage; Recurrent pregnancy loss; RPL; Spontaneous abortion

Indexed keywords

ANEUPLOID; ANTIPHOSPHOLIPID; HEPARIN; LUPUS ANTICOAGULANT; MISCARRIAGE; RECURRENT PREGNANCY LOSS; RPL; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ALGORITHMS; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATIONS; FEMALE; GENETIC TESTING; HUMANS; KARYOTYPING; PARENTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REPRODUCTIVE MEDICINE;

EID: 84894904638     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2013.10.011     Document Type: Review

References (82)

1. The Practice Committee of the American Society for Reproductive Medicine Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012, 98(5):1103-1111.
2. Kutteh W.H. Recurrent pregnancy loss, in precis, an update in obstetrics and gynecology 2007, American College of Obstetrics and Gynecology, Washington, DC.
3. Stephenson M.D. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996, 66:24-29.
4. Jaslow C.R., Carney J.L., Kutteh W.H. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010, 93(4):1234-1243.
5. Lund M., Kamper-Jørgensen M., Nielsen H.S., et al. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of successα. Obstet Gynecol 2012, 119:37-43.
6. Practice Committee of the American Society for Reproductive Medicine Aging and infertility in women. Fertil Steril 2006, 86(5 Suppl 1):S248-S252.
7. Stirrat G.M. Recurrent miscarriage. Lancet 1990, 336:673-675.
8. Lathi R.B., Gray Hazard F.K., Heerema-McKenney A., et al. First trimester miscarriage evaluation. Semin Reprod Med 2011, 29:463-469.
9. Nybo Andersen A.M., Wohlfahrt J., Christens P. Maternal age and fetal loss: population based register linkage study. BMJ 2000, 304:1708-1712.
10. Harger J.H., Archer D.F., Marchese S.G., et al. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol 1983, 62:574-581.
11. Quenby S.M., Farquharson R.G. Predicting recurring miscarriage: what is importantα. Obstet Gynecol 1993, 82:132-138.
12. Roman E. Fetal loss rates and their relationship to pregnancy order. JEpidemiol Community Health 1984, 38:29.
13. Hatasaka H.H. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol 1994, 37:625-634.
14. Sugiura-Ogasawara M., Ozaki Y., Katano K., et al. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod 2012, 27:2297-2303.
15. Foyouzi N., Cedars M.I., Huddleston H.G. Cost-effectiveness of cytogenetic evaluation of products of conception in the patient with a second pregnancy loss. Fertil Steril 2012, 98:151-155.
16. Bernardi L.A., Plunkett B.A., Stephenson M.D. Is chromosome testing of the second miscarriage cost savingα A decision analysis of selective versus universal recurrent pregnancy loss evaluation. Fertil Steril 2012, 98:156-161.
17. Stray-Pedersen B., Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984, 148:140-146.
18. Jaslow C.R., Kutteh W.H. Effect of prior birth and miscarriage frequency on the prevalence of acquired and congenital uterine anomalies in women with recurrent miscarriage: a cross-sectional study. Fertil Steril 2013, 99(7):1916-1922.
19. Sugiura-Ogasawara M., Ozaki Y., Katano K., et al. Uterine anomaly and recurrent pregnancy loss. Semin Reprod Med 2011, 29:514-521.
20. Stovall D.W., Parrish S.B., Van Voorhis B.J., et al. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod 1998, 13:192-197.
21. Surrey E.S., Lietz A.K., Schoolcraft W.B. Impact of intramural leiomyomate in patients with a normal endometrial cavity on invitro fertilization-embryo transfer cycle outcome. Fertil Steril 2001, 75:405-419.
22. American College of Obstetrics and Gynecologist ACOG practice bulletin. Cervical insufficiency. Int J Gynaecol Obstet 2004, 85:81-89.
23. Tuckerman E., Laird S.M., Stewart R., et al. Markers of endometrial function in women with unexplained recurrent pregnancy loss. Hum Reprod 2004, 19:196-205.
24. Smith M.L., Schust D.J. Endocrinology and recurrent early pregnancy loss. Semin Reprod Med 2011, 29:482-490.
25. Cumming D.C., Honore L.H., Scott J.Z., et al. The late luteal phase in infertile women: comparison of simultaneous endometrial biopsy and progesterone levels. Fertil Steril 1985, 43:715-719.
26. Shepard M.K., Senturia Y.D. Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function. Fertil Steril 1977, 28:541-548.
27. Goldstein P., Berrier J., Rosen S., et al. Ameta-analysis of randomized control trials of progestational agents in pregnancy. BJOG 1989, 96:265-274.
28. Haas D.M., Ramsey P.S. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2008, (2). CD003511.
29. Ghazeeri G.S., Kutteh W.H. Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Hum Reprod 2001, 16:2130-2135.
30. De Groot L., Abalovich M., Alexander E.K., et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. JClin Endocrinol Metab 2012, 97:2543-2565.
31. Kutteh W.H., Yetman D.L., Carr A.C., et al. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999, 71:843-848.
32. Mills J.L., Simpson J.L., Driscoll S.G., et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. NEngl J Med 1988, 319:1617-1623.
33. Sills E.S., Perloe M., Palermo G.D. Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes. Eur J Obstet Gynecol Reprod Biol 2000, 91:135-141.
34. Dlugi A.M. Hyperprolactinemic recurrent spontaneous pregnancy loss: a true clinical entity or a spurious findingα. Fertil Steril 1998, 70:253-255. [comment].
35. Hirahara F., Andoh N., Sawai K., et al. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 1998, 70:246-252. [comment].
36. Hofmann G.E., Khoury J., Thie J. Recurrent pregnancy loss and diminished ovarian reserve. Fertil Steril 2000, 74(6):1192-1195.
37. Kutteh W.H. Immunology of multiple endocrinopathies associated with premature ovarian failure. Endocrinologist 1996, 6:462-466.
38. Franklin R.D., Kutteh W.H. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod 2002, 17:2981-2985.
39. Kutteh W.H., Lyda E.C., Abraham S.M., et al. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 1993, 60:449-455.
40. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). JThromb Haemost 2006, 4:295-306.
41. Out H.J., Bruinse H.W., Christians C.M., et al. Aprospective, controlled multicenter study of the obstetric risks of pregnant women with antiphospholipid antibodies. BJOG 1992, 167:26-32.
42. Ernest J.M., Marshburn P.B., Kutteh W.H. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Semin Reprod Med 2011, 29:522-539.
43. Han C.S., Mulla M.J., Brosens J.J., et al. Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstet Gynecol 2011, 118(5):1021-1028.
44. Rand J.H. The antiphospholipid syndrome. Annu Rev Med 2003, 54:409-424.
45. Di Simone N., Ferrazani S., Castellani R., et al. Heparin and low-dose aspirin restore placental human chorionic gonadotropin secretion abolished by antiphospholipid antibody containing sera. Hum Reprod 1997, 12:2061-2065.
46. Empson M., Lassere M., Craig J.C., et al. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002, 99:135-144.
47. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584-1589.
48. Pattison N.S., Chamley L.W., Birdsall M., et al. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndromeα A randomized controlled trial. Am J Obstet Gynecol 2000, 183:1008-1012.
49. Ziakas P.D., Pavlou M., Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010, 115(6):1256-1262.
50. Mulla M.J., Brosens J.J., Chamley L.W., et al. Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod Immunol 2009, 62(2):96-111.
51. Committee on Practice Bulletins-Obstetrics, American College of Obstetricians and Gynecologists Practice Bulletin No. 132: antiphospholipid syndrome. Obstet Gynecol 2012, 120(6):1514-1521.
52. Jablonowska B., Selbing A., Palfi M., et al. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study. Hum Reprod 1999, 14:838-841.
53. Stephenson M.D., Kutteh W.H., Purkiss S., et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010, 25(9):2203-2209.
54. Coulam C.B., Acacio B. Does immunotherapy for treatment of reproductive failure enhance live birthsα. Am J Reprod Immunol 2012, 67(4):296-304.
55. Scott J.R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2003, (1). CD000112 [update of Cochrane Database Syst Rev. 2000;(2):CD000112; PMID: 10796135].
56. Laskin C.A., Bombardier C., Hannah M.E., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. NEngl J Med 1997, 337:148-153.
57. Penta M., Lukic A., Conte M.P., et al. Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. New Microbiol 2003, 26:329-337.
58. Lockwood C., Wendel G., Committee on Practice Bulletins-Obstetrics Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstet Gynecol 2011, 118:730-740.
59. Hirshfeld-Cytron J., Sugiura-Ogasawara M., Stephenson M.D. Management of recurrent pregnancy loss associated with a parental carrier of a reciprocal translocation: a systematic review. Semin Reprod Med 2011, 29:470-481.
60. Hassold T., Chen N., Funkhouser J., et al. Acytogenetic study of 1000 spontaneous abortions. Ann Hum Genet 1980, 44(Pt 2):151-178.
61. Werner M., Reh A., Grifo J., et al. Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. JAssist Reprod Genet 2012, 29:817-820.
62. Nayak S., Pavone M.E., Milad M., et al. Aneuploidy rates in failed pregnancies following assisted reproductive technology. JWomens Health (Larchmt) 2011, 20:1239-1243.
63. Coulam C.B., Goodman C., Dorfmann A. Comparison of ultrasonographic findings in spontaneous abortions with normal and abnormal karyotypes. Hum Reprod 1997, 12:823-826.
64. Philipp T., Philipp K., Reiner A., et al. Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Reprod 2003, 18:1724-1732.
65. Mastenbroek S., Twisk M., van Echten-Arends J., et al. Invitro fertilization with preimplantation genetic screening. NEngl J Med 2007, 357(1):9-17.
66. Practice Committee of Society for Assisted Reproductive Technology, Practice Committee of American Society for Reproductive Medicine Preimplantation genetic testing: a practice committee opinion. Fertil Steril 2008, 90:S136-S143.
67. Harper J.C., Wilton L., Traeger-Synodinos J., et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update 2012, 18:234-247.
68. Forman E.J., Tao X., Ferry K.M., et al. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod 2012, 27:1217-1222.
69. Schoolcraft W.B., Fragouli E., Stevens J., et al. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril 2010, 94:1700-1706.
70. Brezina P.R., Brezina D.S., Kearns W.G. Preimplantation genetic testing. BMJ 2012, 345:e5908.
71. Wells D., Alfarawati S., Fragouli E. Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod 2008, 14:703-710.
72. Gardella J.R., Hill J.A. Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med 2000, 18(4):407-424.
73. Harlap S., Shiono P.H. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet 1980, 2:173-178.
74. Kline J., Shroat P., Stein Z.A., et al. Drinking during pregnancy and spontaneous abortion. Lancet 1980, 2:176-180.
75. Andersen A.M., Andersen P.K., Olsen J., et al. Moderate alcohol intake during pregnancy and risk of fetal death. Int J Epidemiol 2012, 41(2):405-413.
76. Ness R.B., Grisso J.A., Hrischinger N. Cocaine and tobacco use and the risk of spontaneous abortion. NEngl J Med 1999, 340:333-339.
77. Johnson A.R., Justin Milner J., Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 2012, 249:218-238.
78. Dlugosz L., Bracken M.B. Reproductive effects of caffeine: a review and theoretical analysis. Epidemiol Rev 1992, 4:83-100.
79. Yamazaki J.N., Schull W.J. Perinatal loss and neurological abnormalities among children of the atomic bomb. Nagasaki and Hiroshima revisited, 1949 to 1989. JAMA 1990, 264:605-609.
80. Brent R.L. The effects of embryonic and fetal exposure to x-ray, microwaves, and ultrasound. Clin Perinatol 1986, 13:615.
81. Brigham S.A., Conlon C., Farquharson R.G. Alongitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999, 14:2868-2871.
82. Hyer J.S., Fong S., Kutteh W.H. Predictive value of the presence of an embryonic heartbeat for live birth: comparison of women with and without recurrent pregnancy loss. Fertil Steril 2004, 82:1369-1373.